High levels of serum prostate-specific antigen due to PSA producing follicular non-Hodgkin's lymphoma

European Journal of Haematology

Volumn 79, Issue 2, 2007, Pages 155-158

  Oosterheert, Jan Jelrik ^a,b   Budel, Leo M ^b   Vos, Pieter ^b   Wittebol, Shulamiet ^b  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b MEANDER MEDICAL CENTER   (Netherlands)

Author keywords

Diagnosis; Non Hodgkin's lymphoma; Prostate specific antigen

Indexed keywords

CYCLOPHOSPHAMIDE; PREDNISONE; PROSTATE SPECIFIC ANTIGEN; RITUXIMAB; VINCRISTINE SULFATE;

AGED; ARTICLE; CANCER STAGING; CASE REPORT; DIGITAL RECTAL EXAMINATION; FOLLICULAR LYMPHOMA; HUMAN; LABORATORY TEST; MALE; MICTURITION DISORDER; MULTIPLE CYCLE TREATMENT; NONHODGKIN LYMPHOMA; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROSTATE BIOPSY; TRANSRECTAL ULTRASONOGRAPHY;

AGED; ANTIGENS, CD20; HUMANS; LYMPHOMA, FOLLICULAR; MALE; PROSTATE-SPECIFIC ANTIGEN;

EID: 34447297052     PISSN: 09024441     EISSN: 16000609     Source Type: Journal    
DOI: 10.1111/j.1600-0609.2007.00883.x     Document Type: Article

References (21)

1. Jemal A, Tiwari RC, Murray T, et al. Cancer statistics, 2004. CA Cancer J Clin 2004 54 : 8 29.
2. Dutch National Public Health Compass, Available at: http://www. nationaalkompas.nl. Accessed on August 1, 2006.
3. Greiner TC, Medeiros LJ, Jaffe ES. Non-Hodgkin's lymphoma. Cancer 1995 75 (Suppl. 1 370 380.
4. American Cancer Society. In: American Cancer Society, ed. Cancer facts and figures. New York, 2001 : 5 17.
5. Spencer J, Golding S. CT evaluation of lymph node status at presentation of prostatic carcinoma. Br J Radiol 1992 65 : 199 201.
6. Coakley FV, Lin RY, Schwartz LH, Panicek DM. Mesenteric adenopathy in patients with prostate cancer: frequency and etiology. AJR Am J Roentgenol 2002 178 : 125 127.
7. Djavan B, Keffer JH, Molberg K, Roehrborn CG. False-positive serum prostate-specific antigen values in a patient with non-Hodgkin lymphoma of the kidney. Urology 1995 45 : 875 878.
8. Johnson TR, Barber DB, Teichman JM, Able AC. T-cell lymphocytic lymphoma involving the prostate presenting as elevated PSA in paraplegia: case report. J Spinal Cord Med 1996 19 : 258 260.
9. Nadler RB, Humphrey PA, Smith DS, Catalona WJ, Ratliff TL. Effect of inflammation and benign prostatic hyperplasia on elevated serum prostate specific antigen levels. J Urol 1995 154 : 407 413.
10. Stamey TA, Yang N, Hay AR, McNeal JE, Freiha FS, Redwine E. Prostate-specific antigen as a serum marker for adenocarcinoma of the prostate. N Engl J Med 1987 317 : 909 916.
11. Rae F, Bulmer B, Nicol D, Clements J. The human tissue kallikreins (KLKs 1-3) and a novel KLK1 mRNA transcript are expressed in a renal cell carcinoma cDNA library. Immunopharmacology 1999 45 : 83 88.
12. Borchert GH, Melegos DN, Tomlinson G, Giai M, Roagna R, Ponzone R, Sgro L, Diamandis EP. Molecular forms of prostate-specific antigen in the serum of women with benign and malignant breast diseases. Br J Cancer 1997 76 : 1087 1094.
13. Diamandis EP, Yu H, Sutherland DJ. Detection of prostate-specific antigen immunoreactivity in breast tumors. Breast Cancer Res Treat 1994 32 : 301 310.
14. Mannello F, Barulli S, Malatesta M, Mancini S, Leoni P, Gazzanelli G. Prostate-specific antigen expression in normal human bone marrow cells. Clin Chem 1999 45 : 1102 1103.
15. Riegman PH, Vlietstra RJ, van der Korput HA, Romijn JC, Trapman J. Identification and androgen-regulated expression of two major human glandular kallikrein-1 (hGK-1) mRNA species. Mol Cell Endocrinol 1991 76 : 181 190.
16. Sehgal SN. Rapamune (Sirolimus, rapamycin): an overview and mechanism of action. Ther Drug Monit 1995 17 : 660 665.
17. Hugo F, Dittmar T, Treutler EK, Zanker KS, Kuehn JJ. The Viscum album extract Iscador P does not cause an autocrine interleukin-6 loop in B-Non-Hodgkin's Lymphoma cell lines. Onkologie 2005 28 : 415 420.
18. Kato H, Kinoshita T, Suzuki S, Nagasaka T, Murate T, Saito H, Hotta T. Elevated serum interleukin-6 (IL-6) is derived from neoplastic lymphoid cells in patients with B-cell non-Hodgkin's lymphoma: correlation with extent of IL-6 expression and serum concentration. Br J Haematol 1996 92 : 1014 1021.
19. Kato H, Kinoshita T, Suzuki S, Nagasaka T, Hatano S, Murate T, Saito H, Hotta T. Production and effects of interleukin-6 and other cytokines in patients with non-Hodgkin's lymphoma. Leuk Lymphoma 1998 29 : 71 79.
20. Debes JD, Comuzzi B, Schmidt LJ, Dehm SM, Culig Z, Tindall DJ. p300 regulates androgen receptor-independent expression of prostate-specific antigen in prostate cancer cells treated chronically with interleukin-6. Cancer Res 2005 65 : 5965 5973.
21. Lin DL, Whitney MC, Yao Z, Keller ET. Interleukin-6 induces androgen responsiveness in prostate cancer cells through up-regulation of androgen receptor expression. Clin Cancer Res 2001 7 : 1773 1781.